Approximately 30 lawsuits filed against healthcare goods manufacturer Allergan will be consolidated into a single multidistrict litigation. Plaintiffs in the lawsuits made the request to the Judicial Panel on Multidistrict Litigation over their claims that the company’s breast implant products are responsible for their development or potential development of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
The extraordinarily rare cancer first became ...
continue reading...